U.S., Dec. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07265011) titled 'Ultrasound-Based Estimation of Hepatic Steatosis in Pediatric MASLD' on Nov. 23.
Brief Summary: The purpose of this study is to validate an artificial intelligence (AI)-based algorithm that estimates hepatic steatosis using ultrasound (US) B-mode images in pediatric participants with metabolic dysfunction-associated steatotic liver disease (MASLD). The MRI proton density fat fraction (MRI-PDFF) serves as the reference standard for hepatic fat quantification.
Study Start Date: Dec. 31, 2024
Study Type: INTERVENTIONAL
Condition:
MASLD
Pediatric
Intervention:
DIAGNOSTIC_TEST: Ultrasound and MRI
Participants undergo same-day liver...